Michiaki Matsumoto

Current use of direct oral anticoagulants for atrial fibrillation in Japan: Findings from the SAKURA AF Registry

Yasuo Okumura, Katsuaki Yokoyama, Naoya Matsumoto et al. · Journal of Arrhythmia · 2017 · 97 citations · Full text

Medicine, Cardiology, Pharmacology +12

Clinical Outcomes of Off-Label Dosing of Direct Oral Anticoagulant Therapy Among Japanese Patients With Atrial Fibrillation Identified From the SAKURA AF Registry

Nobuhiro Murata, Yasuo Okumura, Katsuaki Yokoyama et al. · Circulation Journal · 2019 · 81 citations · Full text

Medicine, Cardiology, Pharmacology +10

Three-Year Clinical Outcomes Associated With Warfarin vs. Direct Oral Anticoagulant Use Among Japanese Patients With Atrial Fibrillation　― Findings From the SAKURA AF Registry ―

Yasuo Okumura, Katsuaki Yokoyama, Naoya Matsumoto et al. · Circulation Journal · 2018 · 66 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Development of a model for prediction of coronary atherosclerotic regression: evaluation of high-density lipoprotein cholesterol level and peripheral blood monocyte count

Shigemasa Tani, Michiaki Matsumoto, Takeo Anazawa et al. · Heart and Vessels · 2011 · 44 citations

Medicine, Biostatistics, Cardiology +14

Impact of the Fibrosis-4 Index on Risk Stratification of Cardiovascular Events and Mortality in Patients with Atrial Fibrillation: Findings from a Japanese Multicenter Registry

Yuki Saito, Yasuo Okumura, Koichi Nagashima et al. · Journal of Clinical Medicine · 2020 · 44 citations · Full text

Medicine, Cardiology, Clinical Epidemiology +16